Application
KCNC2 Antibody (C-term) western blot analysis in mouse kidney tissue lysates (35ug/lane).This demonstrates the KCNC2 antibody detected the KCNC2 protein (arrow).| Product Name | KCNC2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | KCNC2; Potassium voltage-gated channel subfamily C member 2; Voltage-gated potassium channel Kv3.2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | KCNC2 Potassium voltage-gated channel subfamily C member 2 Voltage-gated potassium channel Kv3.2 |
|---|---|
| Molecular Weight(MW) | 70226 Da |
| Function | Mediates the voltage-dependent potassium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a potassium-selective channel through which potassium ions may pass in accordance with their electrochemical gradient. Channel properties are modulated by subunit assembly (By similarity) |
| Tissue Specificity | This KCNC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 543-573 amino acids from the C-terminal region of human KCNC2. |
| Cellular Localization | Membrane; Multi-pass membrane protein. |
| Entrez Gene | 3747 |
|---|---|
| Nucleotide Accession | NP_631874.1 NP_631875.1 NP_715624.1 |
Application
KCNC2 Antibody (C-term) western blot analysis in mouse kidney tissue lysates (35ug/lane).This demonstrates the KCNC2 antibody detected the KCNC2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
